Cascade Investment Advisors, Inc. Gilead Sciences, Inc. Transaction History

Cascade Investment Advisors, Inc.

$156 Million
Q3 2024

A detailed history of Cascade Investment Advisors, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cascade Investment Advisors, Inc. holds 2,760 shares of GILD stock, worth $259,302. This represents 0.15% of its overall portfolio holdings.

Number of Shares

2,760

Holding current value

$259,302

% of portfolio

0.15%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 02, 2024	BUY	$66.59 - $83.99 $183,788 - $231,812	2,760 New	2,760 $231,000
Q1 2024 Apr 24, 2024	SELL	$71.58 - $87.29 $8,947 - $10,911	-125 Reduced 4.33%	2,760 $202,000
Q1 2023 May 10, 2023	SELL	$77.31 - $88.08 $361,037 - $411,333	-4,670 Reduced 61.81%	2,885 $239,000
Q4 2022 Jan 26, 2023	SELL	$62.32 - $89.47 $991,012 - $1.42 Million	-15,902 Reduced 67.79%	7,555 $0
Q3 2022 Nov 15, 2022	SELL	$59.54 - $68.01 $75,020 - $85,692	-1,260 Reduced 5.1%	23,457 $1.84 Million
Q2 2022 Aug 11, 2022	SELL	$57.72 - $65.01 $87,041 - $98,035	-1,508 Reduced 5.75%	24,717 $1.53 Billion
Q1 2022 Apr 11, 2022	BUY	$57.92 - $72.58 $83,578 - $104,732	1,443 Added 5.82%	26,225 $1.56 Million
Q4 2021 Feb 10, 2022	BUY	$64.88 - $73.64 $12,132 - $13,770	187 Added 0.76%	24,782 $1.8 Million
Q3 2021 Oct 21, 2021	SELL	$67.69 - $73.03 $47,721 - $51,486	-705 Reduced 2.79%	24,595 $1.72 Billion
Q2 2021 Aug 04, 2021	BUY	$63.47 - $69.35 $9,203 - $10,055	145 Added 0.58%	25,300 $1.74 Million
Q1 2021 Apr 23, 2021	BUY	$60.0 - $68.46 $23,700 - $27,041	395 Added 1.6%	25,155 $1.63 Million
Q4 2020 Jan 21, 2021	BUY	$56.65 - $64.55 $51,551 - $58,740	910 Added 3.82%	24,760 $1.44 Billion
Q3 2020 Oct 14, 2020	BUY	$62.1 - $78.08 $60,547 - $76,128	975 Added 4.26%	23,850 $1.51 Billion
Q2 2020 Jul 15, 2020	SELL	$72.34 - $84.0 $54,616 - $63,420	-755 Reduced 3.2%	22,875 $1.76 Billion
Q1 2020 Apr 21, 2020	SELL	$62.63 - $80.22 $33,193 - $42,516	-530 Reduced 2.19%	23,630 $1.77 Billion
Q4 2019 Jan 22, 2020	SELL	$61.62 - $67.78 $11,091 - $12,200	-180 Reduced 0.74%	24,160 $1.57 Billion
Q3 2019 Oct 22, 2019	BUY	$62.51 - $69.0 $154,399 - $170,430	2,470 Added 11.29%	24,340 $1.54 Billion
Q2 2019 Jul 18, 2019	BUY	$61.87 - $69.38 $44,546 - $49,953	720 Added 3.4%	21,870 $1.48 Billion
Q1 2019 Apr 15, 2019	SELL	$62.53 - $70.05 $6,253 - $7,005	-100 Reduced 0.47%	21,150 $1.37 Billion
Q4 2018 Jan 25, 2019	SELL	$60.54 - $79.0 $15,135 - $19,750	-250 Reduced 1.16%	21,250 $1.33 Billion
Q3 2018 Oct 12, 2018	BUY	$71.28 - $78.92 $22,453 - $24,859	315 Added 1.49%	21,500 $1.66 Billion
Q2 2018 Jul 31, 2018	SELL	$64.88 - $75.68 $114,837 - $133,953	-1,770 Reduced 7.71%	21,185 $1.5 Billion
Q1 2018 Apr 23, 2018	BUY	$72.84 - $88.8 $211,236 - $257,520	2,900 Added 14.46%	22,955 $1.73 Billion
Q4 2017 Jan 17, 2018	SELL	$71.15 - $83.52 $7,115 - $8,352	-100 Reduced 0.5%	20,055 $1.44 Billion
Q3 2017 Oct 12, 2017	BUY	$72.11 - $85.47 $1.45 Million - $1.72 Million	20,155	20,155 $1.63 Billion

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cascade Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cascade Investment Advisors, Inc. with notifications on news.

Account

Cascade Investment Advisors, Inc. Gilead Sciences, Inc. Transaction History